Table 6.
Diabetes (n = 476) | No Diabetes (n = 2012) | P Value | |
---|---|---|---|
No complications, n (%) | 309 (64.9) | 1457 (72.4) | .001 |
Recurrent pulmonary embolism,* n (%) | 8 (1.7) | 30 (1.5) | .76 |
Recurrent deep vein thrombosis,* n (%) | 71 (14.9) | 216 (10.7) | .01 |
Long-term major bleeding,* n (%) | 78 (16.4) | 235 (11.7) | .01 |
In-hospital major bleeding, n (%) | 27 (5.7) | 76 (3.8) | .07 |
Heparin-induced thrombocytopenia,* n (%) | 6 (1.3) | 19 (0.9) | .70 |
In-hospital death, n (%) | 30 (6.3) | 83 (4.1) | .05 |
Death within 30 days of venous thromboembolism diagnosis, n (%) | 45 (9.9) | 146 (7.5) | .10 |
Long-term outcomes data encompassed a median follow-up period of 992 days.